[A Case of Lower Rectal GIST with Anorectal Preservation by Laparoscopic Low Anterior Resection after Imatinib Mesylate Neoadjuvant Therapy].

Q4 Medicine
Tomonori Himan, Hideki Machishi, Hideo Suzuki, Naomi Konishi, Naoki Takahashi, Aya Sugisawa, Kousuke Mizukoshi, Sayuri Hattori
{"title":"[A Case of Lower Rectal GIST with Anorectal Preservation by Laparoscopic Low Anterior Resection after Imatinib Mesylate Neoadjuvant Therapy].","authors":"Tomonori Himan, Hideki Machishi, Hideo Suzuki, Naomi Konishi, Naoki Takahashi, Aya Sugisawa, Kousuke Mizukoshi, Sayuri Hattori","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A 60-year-old man was diagnosed with a rectal gastrointestinal stromal tumor(GIST). Endoscopy revealed a submucosal tumor in the lower rectum near the dentate line. CT and MRI findings showed that the tumor was compressing the prostate and seminal vesicles. To shrink the tumor whilst preserving the anus, 400 mg/day of imatinib mesylate (IM)was administered as preoperative drug therapy. Six months after the initiation of neoadjuvant therapy, the patient underwent laparoscopic low anterior resection of the rectum. Postoperatively, IM was resumed as adjuvant therapy, but was discontinued after 10 months due to the occurrence of side effects. No recurrence of the tumor was observed during a 2 years and 3 months postoperative assessment. We believe that preoperative pharmacotherapy with IM is an effective treatment strategy. Herein, we report the details of this case along with a review of the literature.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 7","pages":"533-535"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

A 60-year-old man was diagnosed with a rectal gastrointestinal stromal tumor(GIST). Endoscopy revealed a submucosal tumor in the lower rectum near the dentate line. CT and MRI findings showed that the tumor was compressing the prostate and seminal vesicles. To shrink the tumor whilst preserving the anus, 400 mg/day of imatinib mesylate (IM)was administered as preoperative drug therapy. Six months after the initiation of neoadjuvant therapy, the patient underwent laparoscopic low anterior resection of the rectum. Postoperatively, IM was resumed as adjuvant therapy, but was discontinued after 10 months due to the occurrence of side effects. No recurrence of the tumor was observed during a 2 years and 3 months postoperative assessment. We believe that preoperative pharmacotherapy with IM is an effective treatment strategy. Herein, we report the details of this case along with a review of the literature.

[1例下直肠间质瘤经甲磺酸伊马替尼新辅助治疗后经腹腔镜下前切除术保留肛门直肠]。
一位60岁的男性被诊断为直肠胃肠道间质瘤(GIST)。内镜检查显示直肠下部齿状线附近的粘膜下肿瘤。CT及MRI显示肿瘤压迫前列腺及精囊。为了在保留肛门的同时缩小肿瘤,术前给予甲磺酸伊马替尼(imatinib, IM) 400 mg/d。开始新辅助治疗6个月后,患者行腹腔镜直肠低位前切除术。术后恢复IM作为辅助治疗,10个月后因出现不良反应停药。术后2年零3个月未见肿瘤复发。我们认为术前IM药物治疗是一种有效的治疗策略。在此,我们报告这个病例的细节以及文献综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
337
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信